The full report is titled “Salicylate (Salsalate) in Patients With Type 2 Diabetes. A Randomized Trial.” It is in the 2 July 2013 issue of Annals of Internal Medicine (volume 159, pages 1-12). The authors are A.B. Goldfine, V. Fonseca, K.A. Jablonski, Y.D.I. Chen, L. Tipton, M.A. Staten, and S.E. Shoelson, for the Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team.
Salsalate for Type 2 Diabetes Mellitus. Ann Intern Med. 2013;159:I–32. doi: https://doi.org/10.7326/0003-4819-159-1-201307020-00001
Download citation file:
Published: Ann Intern Med. 2013;159(1):I-32.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use